Trials / Sponsors / Sonnet BioTherapeutics
Sonnet BioTherapeutics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer Advanced Solid Tumor, Platinum-resistant Ovarian Cancer | Phase 1 / Phase 2 | 2023-09-15 |
| Terminated | SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN) Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 1 / Phase 2 | 2022-10-27 |
| Completed | Study of SON-1010 (IL12-FHAB) in Healthy Adults Healthy Adult | EARLY_Phase 1 | 2022-07-27 |
| Active Not Recruiting | Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors Advanced Solid Tumor, Soft Tissue Sarcoma Adult | Phase 1 | 2022-04-20 |